Aura Biosciences Inc (NAS:AURA)
$ 8.22 0.09 (1.11%) Market Cap: 410.60 Mil Enterprise Value: 250.81 Mil PE Ratio: 0 PB Ratio: 2.34 GF Score: 40/100

Aura Biosciences Inc Corporate Analyst Meeting Transcript

Mar 22, 2022 / 03:00PM GMT
Release Date Price: $21.48 (-0.83%)
Operator

Good morning. My name is Lou, and I'll be your conference operator today. At this time, I would like to remind everyone that it is Aura Biosciences' Investor Day for Ocular Oncology. (Operator Instructions) Please be advised this call is being recorded at the company's request.

I would like to turn the call over to Elisabet de los Pinos, Chief Executive Officer of Aura Biosciences.

Elisabet de los Pinos
Aura Biosciences, Inc. - Founder, CEO, President & Director

Thank you, and welcome, everyone, to the first Ocular Oncology Investor Day. This is an exciting time at Aura. We're going to have a very good agenda. And most importantly, we are joined today by 2 world-renowned ocular oncology experts.

So we're going to focus, initially, on a moderated Q&A, where Dr. Cadmus Rich is going to be interviewing the 2 ocular oncologists that are here with us today. And then after that, we will have Aura and Cadmus present our clinical data. After the clinical data is presented, we will have the opportunity for the audience Q&A and some

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot